FHTXVSNIVF• 12 Months (Normalized)
FHTX vs NIVF (Foghorn Therapeutics Inc. vs NewGenIvf Group Limited)
Showing Closing Date Range from Oct 6, 2025 to Oct 6, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
FHTX Performance $1.97
-56.51%
Foghorn Therapeutics Inc.
Normalized Baseline0.00%
NIVF Performance $0.1
-99.99%
NewGenIvf Group Limited
Normalized Baseline0.00%
Alpha Spread Margin FHTX LEADS
+43.48 pts
FHTX outperforming by 43.48 percentage points
FHTXNIVF
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
FHTX NIVF
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(252 dates)
| Date | FHTX Price | FHTX Gain (%) | NIVF Price | NIVF Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 06, 2026 | $1.97 | -56.51% | $0.10 | -99.99% | +43.48% |
| Oct 05, 2026 | $2.00 | -55.85% | $0.11 | -99.99% | +44.14% |
| Oct 02, 2026 | $2.02 | -55.41% | $0.13 | -99.99% | +44.58% |
| Oct 01, 2026 | $2.92 | -35.54% | $0.10 | -99.99% | +64.45% |
| Sep 30, 2026 | $3.57 | -21.19% | $0.17 | -99.98% | +78.79% |
| Sep 29, 2026 | $- | $0.07 | -99.99% | - | |
| Sep 28, 2026 | $- | $0.35 | -99.96% | - | |
| Sep 25, 2026 | $3.54 | -21.85% | $- | - | |
| Sep 24, 2026 | $3.60 | -20.53% | $- | - | |
| Sep 23, 2026 | $3.87 | -14.57% | $0.59 | -99.94% | +85.37% |
| Sep 22, 2026 | $4.24 | -6.40% | $0.73 | -99.92% | +93.52% |
| Sep 21, 2026 | $4.15 | -8.39% | $0.72 | -99.92% | +91.53% |
| Sep 18, 2026 | $4.14 | -8.61% | $0.72 | -99.92% | +91.31% |
| Sep 17, 2026 | $4.20 | -7.28% | $0.72 | -99.92% | +92.64% |
| Sep 16, 2026 | $4.17 | -7.95% | $0.79 | -99.92% | +91.97% |
Page 1 of 17